

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.97087483 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.97087483 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.69440231 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.69440231 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.51944170 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22670839 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.11373501 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.11373501 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.11373501 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.81692741 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.74757633 |
| 12 | urea cycle (GO:0000050) | 5.48562844 |
| 13 | urea metabolic process (GO:0019627) | 5.48562844 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.46236773 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.36953097 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.33635122 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.23342143 |
| 18 | cysteine metabolic process (GO:0006534) | 5.14101074 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.04837189 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 5.03109081 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 4.96299923 |
| 22 | bile acid metabolic process (GO:0008206) | 4.96196050 |
| 23 | homocysteine metabolic process (GO:0050667) | 4.94058115 |
| 24 | phospholipid efflux (GO:0033700) | 4.90571089 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.83725705 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 4.82046184 |
| 27 | bile acid and bile salt transport (GO:0015721) | 4.81951419 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.79837350 |
| 29 | protein carboxylation (GO:0018214) | 4.77332127 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.77332127 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.76191640 |
| 32 | behavioral response to nicotine (GO:0035095) | 4.74751566 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.74449442 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.72718161 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.72390773 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.72304385 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.72192343 |
| 38 | drug catabolic process (GO:0042737) | 4.71512785 |
| 39 | regulation of protein activation cascade (GO:2000257) | 4.70342870 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.67400180 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.67400180 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.67400180 |
| 43 | epoxygenase P450 pathway (GO:0019373) | 4.56686554 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.53829935 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.53829935 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 4.53497116 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.53497116 |
| 48 | lysine metabolic process (GO:0006553) | 4.52877737 |
| 49 | lysine catabolic process (GO:0006554) | 4.52877737 |
| 50 | cellular glucuronidation (GO:0052695) | 4.51299400 |
| 51 | intestinal cholesterol absorption (GO:0030299) | 4.50010913 |
| 52 | L-fucose catabolic process (GO:0042355) | 4.46856920 |
| 53 | fucose catabolic process (GO:0019317) | 4.46856920 |
| 54 | L-fucose metabolic process (GO:0042354) | 4.46856920 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.46404746 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.40009029 |
| 57 | regulation of complement activation (GO:0030449) | 4.38256054 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.36546266 |
| 59 | cholesterol efflux (GO:0033344) | 4.35240209 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 4.33043637 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 4.24808817 |
| 62 | amine catabolic process (GO:0009310) | 4.24808817 |
| 63 | regulation of bile acid biosynthetic process (GO:0070857) | 4.24334546 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 4.16458576 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.08321897 |
| 66 | ketone body metabolic process (GO:1902224) | 4.07715623 |
| 67 | sulfation (GO:0051923) | 4.06904279 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.04758840 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.04688098 |
| 70 | uronic acid metabolic process (GO:0006063) | 4.04534853 |
| 71 | glucuronate metabolic process (GO:0019585) | 4.04534853 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.02086273 |
| 73 | flavonoid metabolic process (GO:0009812) | 4.00508689 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.97854585 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.96582275 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.96582275 |
| 77 | regulation of guanylate cyclase activity (GO:0031282) | 3.95043096 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92897023 |
| 79 | glutamate metabolic process (GO:0006536) | 3.91133040 |
| 80 | drug transmembrane transport (GO:0006855) | 3.91004699 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86808218 |
| 82 | exogenous drug catabolic process (GO:0042738) | 3.86166929 |
| 83 | cholesterol homeostasis (GO:0042632) | 3.84146400 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.83337480 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.83239555 |
| 86 | glycine metabolic process (GO:0006544) | 3.82954966 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.81178198 |
| 88 | sterol homeostasis (GO:0055092) | 3.80260149 |
| 89 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.78857927 |
| 90 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.78857927 |
| 91 | arginine metabolic process (GO:0006525) | 3.77934214 |
| 92 | intestinal absorption (GO:0050892) | 3.76966917 |
| 93 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.76355384 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.73419535 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.73205356 |
| 96 | ethanol oxidation (GO:0006069) | 3.72623695 |
| 97 | angiotensin maturation (GO:0002003) | 3.70536685 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.67823884 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.65595067 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.63493434 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.61761104 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.61386404 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.58438927 |
| 104 | aldehyde catabolic process (GO:0046185) | 3.57710986 |
| 105 | urate metabolic process (GO:0046415) | 3.57667367 |
| 106 | drug metabolic process (GO:0017144) | 3.57481585 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.57237882 |
| 108 | organic acid catabolic process (GO:0016054) | 3.56031949 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.56031949 |
| 110 | NAD biosynthetic process (GO:0009435) | 3.53788719 |
| 111 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.51400788 |
| 112 | alkaloid metabolic process (GO:0009820) | 3.50844952 |
| 113 | fibrinolysis (GO:0042730) | 3.49978157 |
| 114 | sulfate transmembrane transport (GO:1902358) | 3.49255483 |
| 115 | vitamin biosynthetic process (GO:0009110) | 3.44037132 |
| 116 | transepithelial transport (GO:0070633) | 3.42225873 |
| 117 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.35519257 |
| 118 | positive regulation of fatty acid transport (GO:2000193) | 3.26236121 |
| 119 | oxidative demethylation (GO:0070989) | 3.21726462 |
| 120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.11718880 |
| 121 | positive regulation of icosanoid secretion (GO:0032305) | 3.03756464 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03360970 |
| 123 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.98337515 |
| 124 | nephron epithelium morphogenesis (GO:0072088) | 2.96540108 |
| 125 | nephron tubule morphogenesis (GO:0072078) | 2.96540108 |
| 126 | indole-containing compound metabolic process (GO:0042430) | 2.92007676 |
| 127 | primary amino compound metabolic process (GO:1901160) | 2.90499251 |
| 128 | sulfate transport (GO:0008272) | 2.89896873 |
| 129 | positive regulation of fatty acid oxidation (GO:0046321) | 2.88782220 |
| 130 | phenylpropanoid metabolic process (GO:0009698) | 2.88775855 |
| 131 | heme transport (GO:0015886) | 2.86599622 |
| 132 | fucosylation (GO:0036065) | 2.85735594 |
| 133 | kidney morphogenesis (GO:0060993) | 2.85207309 |
| 134 | glycerol metabolic process (GO:0006071) | 2.84110054 |
| 135 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75874887 |
| 136 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75874887 |
| 137 | omega-hydroxylase P450 pathway (GO:0097267) | 2.73207298 |
| 138 | quinone biosynthetic process (GO:1901663) | 2.72945537 |
| 139 | L-ascorbic acid metabolic process (GO:0019852) | 2.72264511 |
| 140 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.72194050 |
| 141 | endocrine process (GO:0050886) | 2.72194050 |
| 142 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.72194050 |
| 143 | lipoprotein transport (GO:0042953) | 2.70522161 |
| 144 | nucleobase catabolic process (GO:0046113) | 2.65817249 |
| 145 | digestion (GO:0007586) | 2.64968717 |
| 146 | regulation of cGMP biosynthetic process (GO:0030826) | 2.54886345 |
| 147 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.53502965 |
| 148 | vitamin transmembrane transport (GO:0035461) | 2.53338360 |
| 149 | endocrine pancreas development (GO:0031018) | 2.53049651 |
| 150 | serotonin metabolic process (GO:0042428) | 2.52818321 |
| 151 | proline transport (GO:0015824) | 2.52646947 |
| 152 | S-adenosylmethionine metabolic process (GO:0046500) | 2.49368218 |
| 153 | auditory receptor cell differentiation (GO:0042491) | 2.48388524 |
| 154 | alditol metabolic process (GO:0019400) | 2.48280871 |
| 155 | regulation of systemic arterial blood pressure (GO:0003073) | 2.47905384 |
| 156 | sulfur compound transport (GO:0072348) | 2.47221208 |
| 157 | diacylglycerol metabolic process (GO:0046339) | 2.45087215 |
| 158 | cytidine deamination (GO:0009972) | 2.44913225 |
| 159 | cytidine metabolic process (GO:0046087) | 2.44913225 |
| 160 | cytidine catabolic process (GO:0006216) | 2.44913225 |
| 161 | vitamin transport (GO:0051180) | 2.44611493 |
| 162 | peptide hormone processing (GO:0016486) | 2.43857139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.80485941 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.81527794 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.75606128 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17530546 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.88992787 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65582048 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90554267 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81548133 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67726842 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.26502172 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 3.06144313 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50339437 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.33205299 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21698061 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16255350 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.03520210 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00031136 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7543971 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90753464 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88255348 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86976399 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78104862 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76509904 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74642086 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.71193171 |
| 26 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69531841 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65486581 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64728846 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63554733 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.63281005 |
| 31 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.59237334 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56664858 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56353373 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55274085 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54610005 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53332305 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52596861 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51707504 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49289612 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47312125 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46652893 |
| 42 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.44208967 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.44208967 |
| 44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42795728 |
| 45 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41335961 |
| 46 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40113063 |
| 47 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.36358785 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35967532 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35848083 |
| 50 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35591917 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35591917 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.34237696 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33892454 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33551744 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31569060 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30836436 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30836436 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29720407 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29483315 |
| 60 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29203632 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28376981 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26847598 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.26024848 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25612416 |
| 65 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24747936 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24119418 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23403179 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19605260 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18313957 |
| 70 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16974626 |
| 71 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16966880 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16744597 |
| 73 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16371538 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15725372 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14074219 |
| 76 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.12828772 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12152943 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11757058 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10372727 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09815844 |
| 81 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.08274214 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07905975 |
| 83 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07561223 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.07236157 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06608809 |
| 86 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05501617 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05351174 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05125594 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04226361 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02739378 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.02633747 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02562777 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02382150 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02321158 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02316288 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01697112 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01342702 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00946392 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00421070 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00421070 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99893398 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97642191 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93894080 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87952635 |
| 105 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85246198 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83399620 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80052195 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79829319 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77108965 |
| 110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76671734 |
| 111 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76461270 |
| 112 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75851264 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75822470 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75196606 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75124589 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73070287 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72597505 |
| 118 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.72436605 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72149370 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72149370 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72086585 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71358503 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70745514 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70333104 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69211277 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68448637 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68081614 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67078675 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66875970 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.65701737 |
| 131 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.65369684 |
| 132 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64524945 |
| 133 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.64034937 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63489224 |
| 135 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63239643 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63225252 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.62954987 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62713204 |
| 139 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62592212 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62585176 |
| 141 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62527215 |
| 142 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.62152380 |
| 143 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61391589 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61150172 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60732411 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.57917574 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57370155 |
| 148 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56939692 |
| 149 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56771055 |
| 150 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.55695661 |
| 151 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.55193734 |
| 152 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55173304 |
| 153 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55076435 |
| 154 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54515089 |
| 155 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54426810 |
| 156 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53807447 |
| 157 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53740574 |
| 158 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.51292706 |
| 159 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.50058760 |
| 160 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.47814351 |
| 161 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.47528361 |
| 162 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.45524001 |
| 163 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.45416024 |
| 164 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.45346890 |
| 165 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.45032788 |
| 166 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44975794 |
| 167 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.44452515 |
| 168 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44437549 |
| 169 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44206165 |
| 170 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43996005 |
| 171 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.43559577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05181468 |
| 2 | MP0005360_urolithiasis | 8.03747068 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35820242 |
| 4 | MP0005365_abnormal_bile_salt | 6.00774713 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04592208 |
| 6 | MP0003252_abnormal_bile_duct | 4.21571153 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.80658039 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.43808036 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.21652961 |
| 10 | MP0009840_abnormal_foam_cell | 3.10435326 |
| 11 | MP0004147_increased_porphyrin_level | 3.00953241 |
| 12 | MP0003195_calcinosis | 2.78993608 |
| 13 | MP0005332_abnormal_amino_acid | 2.72293976 |
| 14 | MP0005083_abnormal_biliary_tract | 2.53315847 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.49323499 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.16988629 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.13722323 |
| 18 | MP0003868_abnormal_feces_composition | 2.06882989 |
| 19 | MP0000609_abnormal_liver_physiology | 2.02372398 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.99481250 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.98836536 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.91640766 |
| 23 | MP0009697_abnormal_copulation | 1.79633625 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.74580466 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.69374871 |
| 26 | MP0001485_abnormal_pinna_reflex | 1.64209677 |
| 27 | MP0001764_abnormal_homeostasis | 1.62340291 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.45784662 |
| 29 | MP0001664_abnormal_digestion | 1.45240940 |
| 30 | MP0005645_abnormal_hypothalamus_physiol | 1.44828154 |
| 31 | MP0005451_abnormal_body_composition | 1.44719655 |
| 32 | MP0002938_white_spotting | 1.42926467 |
| 33 | MP0002102_abnormal_ear_morphology | 1.42434568 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.41245055 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40686612 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.39822101 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.36873424 |
| 38 | MP0004885_abnormal_endolymph | 1.34344704 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.34233634 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.30984743 |
| 41 | MP0003122_maternal_imprinting | 1.29209877 |
| 42 | MP0008877_abnormal_DNA_methylation | 1.21561414 |
| 43 | MP0004142_abnormal_muscle_tone | 1.21160301 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.16520318 |
| 45 | MP0003879_abnormal_hair_cell | 1.16134804 |
| 46 | MP0009745_abnormal_behavioral_response | 1.15966049 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.14169926 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.13639832 |
| 49 | MP0002272_abnormal_nervous_system | 1.12935575 |
| 50 | MP0003186_abnormal_redox_activity | 1.12619998 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.12412932 |
| 52 | MP0002254_reproductive_system_inflammat | 1.07891163 |
| 53 | MP0003136_yellow_coat_color | 1.07793838 |
| 54 | MP0009764_decreased_sensitivity_to | 1.04144960 |
| 55 | MP0005647_abnormal_sex_gland | 1.03697196 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.02491448 |
| 57 | MP0000598_abnormal_liver_morphology | 1.02129219 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.01053129 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 1.00595759 |
| 60 | MP0003011_delayed_dark_adaptation | 0.99491786 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 0.99455638 |
| 62 | MP0002733_abnormal_thermal_nociception | 0.98690191 |
| 63 | MP0004742_abnormal_vestibular_system | 0.98532611 |
| 64 | MP0004043_abnormal_pH_regulation | 0.93668734 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.92384079 |
| 66 | MP0005253_abnormal_eye_physiology | 0.91842812 |
| 67 | MP0004270_analgesia | 0.91839090 |
| 68 | MP0002064_seizures | 0.91345686 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 0.91343782 |
| 70 | MP0002557_abnormal_social/conspecific_i | 0.90388266 |
| 71 | MP0000427_abnormal_hair_cycle | 0.89803893 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.89150151 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.88529933 |
| 74 | MP0004133_heterotaxia | 0.88436674 |
| 75 | MP0001529_abnormal_vocalization | 0.86994247 |
| 76 | MP0003283_abnormal_digestive_organ | 0.86571511 |
| 77 | MP0006276_abnormal_autonomic_nervous | 0.84963230 |
| 78 | MP0002078_abnormal_glucose_homeostasis | 0.84938519 |
| 79 | MP0005408_hypopigmentation | 0.84223232 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.84023623 |
| 81 | MP0008469_abnormal_protein_level | 0.83815249 |
| 82 | MP0009763_increased_sensitivity_to | 0.83441486 |
| 83 | MP0009046_muscle_twitch | 0.82868287 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.82801541 |
| 85 | MP0001486_abnormal_startle_reflex | 0.81340018 |
| 86 | MP0001970_abnormal_pain_threshold | 0.81167320 |
| 87 | MP0004924_abnormal_behavior | 0.78889835 |
| 88 | MP0005386_behavior/neurological_phenoty | 0.78889835 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 0.77375994 |
| 90 | MP0005389_reproductive_system_phenotype | 0.75219207 |
| 91 | MP0003866_abnormal_defecation | 0.74166157 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.74072073 |
| 93 | MP0003646_muscle_fatigue | 0.73444163 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.73036906 |
| 95 | MP0002736_abnormal_nociception_after | 0.72740647 |
| 96 | MP0000604_amyloidosis | 0.72264118 |
| 97 | MP0001905_abnormal_dopamine_level | 0.72206790 |
| 98 | MP0005410_abnormal_fertilization | 0.71547822 |
| 99 | MP0005448_abnormal_energy_balance | 0.71361991 |
| 100 | MP0002572_abnormal_emotion/affect_behav | 0.71107536 |
| 101 | MP0001188_hyperpigmentation | 0.70775621 |
| 102 | MP0001756_abnormal_urination | 0.70603485 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.70443879 |
| 104 | MP0002160_abnormal_reproductive_system | 0.70151335 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.70049403 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.69546791 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.68751197 |
| 108 | MP0005334_abnormal_fat_pad | 0.68208413 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 0.67897015 |
| 110 | MP0000026_abnormal_inner_ear | 0.67839264 |
| 111 | MP0003705_abnormal_hypodermis_morpholog | 0.66620098 |
| 112 | MP0002822_catalepsy | 0.66286636 |
| 113 | MP0003718_maternal_effect | 0.65605721 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.65043736 |
| 115 | MP0002928_abnormal_bile_duct | 0.64733452 |
| 116 | MP0005535_abnormal_body_temperature | 0.64208774 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.63473494 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.62613506 |
| 119 | MP0002971_abnormal_brown_adipose | 0.62245915 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.61104824 |
| 121 | MP0005266_abnormal_metabolism | 0.59723194 |
| 122 | MP0005670_abnormal_white_adipose | 0.58689805 |
| 123 | MP0009053_abnormal_anal_canal | 0.56844667 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.56773668 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.53634421 |
| 126 | MP0005395_other_phenotype | 0.53069622 |
| 127 | MP0003953_abnormal_hormone_level | 0.52328559 |
| 128 | MP0002132_abnormal_respiratory_system | 0.48886737 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.47517314 |
| 130 | MP0001661_extended_life_span | 0.46502259 |
| 131 | MP0000579_abnormal_nail_morphology | 0.46444508 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.46081116 |
| 133 | MP0005166_decreased_susceptibility_to | 0.45603936 |
| 134 | MP0005464_abnormal_platelet_physiology | 0.43445034 |
| 135 | MP0000462_abnormal_digestive_system | 0.43106409 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.42766027 |
| 137 | MP0001944_abnormal_pancreas_morphology | 0.39814811 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.39169315 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.38698140 |
| 140 | MP0002796_impaired_skin_barrier | 0.37733929 |
| 141 | MP0008872_abnormal_physiological_respon | 0.37509863 |
| 142 | MP0003724_increased_susceptibility_to | 0.37317549 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.37116460 |
| 144 | MP0000566_synostosis | 0.35976452 |
| 145 | MP0008873_increased_physiological_sensi | 0.35786258 |
| 146 | MP0001663_abnormal_digestive_system | 0.35606382 |
| 147 | MP0001845_abnormal_inflammatory_respons | 0.35509328 |
| 148 | MP0003690_abnormal_glial_cell | 0.35205727 |
| 149 | MP0003300_gastrointestinal_ulcer | 0.34940287 |
| 150 | MP0005381_digestive/alimentary_phenotyp | 0.33626775 |
| 151 | MP0006082_CNS_inflammation | 0.32813432 |
| 152 | MP0001881_abnormal_mammary_gland | 0.32392002 |
| 153 | MP0002693_abnormal_pancreas_physiology | 0.32095609 |
| 154 | MP0009115_abnormal_fat_cell | 0.30995290 |
| 155 | MP0003436_decreased_susceptibility_to | 0.30788574 |
| 156 | MP0002168_other_aberrant_phenotype | 0.29923163 |
| 157 | MP0009384_cardiac_valve_regurgitation | 0.29753778 |
| 158 | MP0004130_abnormal_muscle_cell | 0.29691039 |
| 159 | MP0008874_decreased_physiological_sensi | 0.28455100 |
| 160 | MP0005666_abnormal_adipose_tissue | 0.27587251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.23649241 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.98313586 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47896983 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.42384777 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.36176341 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.05886801 |
| 7 | Xanthomatosis (HP:0000991) | 5.87663734 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.88756853 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 4.78844080 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.66761770 |
| 11 | Complement deficiency (HP:0004431) | 4.64697031 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.59858477 |
| 13 | Fat malabsorption (HP:0002630) | 4.49163347 |
| 14 | Joint hemorrhage (HP:0005261) | 4.44594499 |
| 15 | Hyperammonemia (HP:0001987) | 4.38287947 |
| 16 | Epidermoid cyst (HP:0200040) | 4.36659126 |
| 17 | Hyperglycinemia (HP:0002154) | 4.22438663 |
| 18 | Hyperglycinuria (HP:0003108) | 4.16124651 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15465914 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13612958 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11830855 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.10602737 |
| 23 | Ketosis (HP:0001946) | 4.09677465 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06579778 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.92841771 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92841771 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.79729537 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.73840440 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.68781441 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.66144786 |
| 31 | Decreased circulating renin level (HP:0003351) | 3.56581748 |
| 32 | Congenital stationary night blindness (HP:0007642) | 3.51982143 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.50489546 |
| 34 | Pancreatic cysts (HP:0001737) | 3.42274559 |
| 35 | Abnormality of complement system (HP:0005339) | 3.35052799 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.34266167 |
| 37 | Hypothermia (HP:0002045) | 3.34205547 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27924502 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.27013035 |
| 40 | Ketoacidosis (HP:0001993) | 3.24579925 |
| 41 | Abnormality of vitamin B metabolism (HP:0004340) | 3.22672488 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17428843 |
| 43 | Acanthocytosis (HP:0001927) | 3.14271696 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 3.13366632 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 3.10670029 |
| 46 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.08712657 |
| 47 | Hypoglycemic seizures (HP:0002173) | 3.07779579 |
| 48 | Steatorrhea (HP:0002570) | 3.07448605 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 3.06128832 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 3.02327179 |
| 51 | Pancreatic fibrosis (HP:0100732) | 3.01542734 |
| 52 | True hermaphroditism (HP:0010459) | 3.00277883 |
| 53 | Metabolic alkalosis (HP:0200114) | 2.97965658 |
| 54 | Metabolic acidosis (HP:0001942) | 2.93849736 |
| 55 | Confusion (HP:0001289) | 2.88943401 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.88537277 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.88537277 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.85172454 |
| 59 | Pendular nystagmus (HP:0012043) | 2.83102518 |
| 60 | Malnutrition (HP:0004395) | 2.82468435 |
| 61 | Type II lissencephaly (HP:0007260) | 2.82088766 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.79888475 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.76108870 |
| 64 | Vascular calcification (HP:0004934) | 2.74273535 |
| 65 | Hyperventilation (HP:0002883) | 2.71279716 |
| 66 | Myocardial infarction (HP:0001658) | 2.70439881 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.70396781 |
| 68 | Abnormality of renin-angiotensin system (HP:0000847) | 2.66377865 |
| 69 | Spontaneous abortion (HP:0005268) | 2.65552185 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.63426083 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.63256964 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63256964 |
| 73 | Lethargy (HP:0001254) | 2.63139202 |
| 74 | Gout (HP:0001997) | 2.58934908 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.58716532 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.58716532 |
| 77 | Nephronophthisis (HP:0000090) | 2.54865777 |
| 78 | Skin nodule (HP:0200036) | 2.52215417 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.49764352 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.49502709 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.46451915 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.46024182 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.44578619 |
| 84 | Late onset (HP:0003584) | 2.42693201 |
| 85 | Symptomatic seizures (HP:0011145) | 2.39313030 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.38789143 |
| 87 | Irritability (HP:0000737) | 2.38652006 |
| 88 | Decreased central vision (HP:0007663) | 2.36243450 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.33520636 |
| 90 | Pancreatitis (HP:0001733) | 2.32251060 |
| 91 | Chorioretinal atrophy (HP:0000533) | 2.32055638 |
| 92 | Renal cortical cysts (HP:0000803) | 2.31214949 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 2.30709347 |
| 94 | Glycosuria (HP:0003076) | 2.30709347 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.28910207 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.28402303 |
| 97 | Abnormality of the renal medulla (HP:0100957) | 2.28162889 |
| 98 | Cerebral edema (HP:0002181) | 2.26873477 |
| 99 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26733717 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25575305 |
| 101 | Abnormality of alanine metabolism (HP:0010916) | 2.25575305 |
| 102 | Hyperalaninemia (HP:0003348) | 2.25575305 |
| 103 | Alkalosis (HP:0001948) | 2.25547811 |
| 104 | Glomerulonephritis (HP:0000099) | 2.23300274 |
| 105 | Poikilocytosis (HP:0004447) | 2.22539221 |
| 106 | Enlarged kidneys (HP:0000105) | 2.21853405 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.20823083 |
| 108 | Cholecystitis (HP:0001082) | 2.20823083 |
| 109 | Cystic liver disease (HP:0006706) | 2.20731212 |
| 110 | Rickets (HP:0002748) | 2.19307661 |
| 111 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17262977 |
| 112 | Cholelithiasis (HP:0001081) | 2.17100592 |
| 113 | Mitral stenosis (HP:0001718) | 2.16448630 |
| 114 | Tubular atrophy (HP:0000092) | 2.15067818 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.13102123 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.12570860 |
| 117 | Chronic hepatic failure (HP:0100626) | 2.11970542 |
| 118 | Menorrhagia (HP:0000132) | 2.11925502 |
| 119 | Hyperglycemia (HP:0003074) | 2.09529103 |
| 120 | Esophageal varix (HP:0002040) | 2.07630703 |
| 121 | Potter facies (HP:0002009) | 2.07486560 |
| 122 | Facial shape deformation (HP:0011334) | 2.07486560 |
| 123 | Gingival bleeding (HP:0000225) | 2.07318183 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06778388 |
| 125 | Vomiting (HP:0002013) | 2.06434073 |
| 126 | Methylmalonic acidemia (HP:0002912) | 2.06393514 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 2.06388216 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06275309 |
| 129 | Progressive cerebellar ataxia (HP:0002073) | 2.05094453 |
| 130 | Cerebellar dysplasia (HP:0007033) | 2.04638702 |
| 131 | Keratoconus (HP:0000563) | 2.02691858 |
| 132 | Increased corneal curvature (HP:0100692) | 2.02691858 |
| 133 | Large for gestational age (HP:0001520) | 2.02483562 |
| 134 | Neonatal onset (HP:0003623) | 1.99473476 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.98399039 |
| 136 | Medial flaring of the eyebrow (HP:0010747) | 1.97754127 |
| 137 | Spastic diplegia (HP:0001264) | 1.96649074 |
| 138 | Amyloidosis (HP:0011034) | 1.95585232 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.95148385 |
| 140 | Brushfield spots (HP:0001088) | 1.94033028 |
| 141 | Acute encephalopathy (HP:0006846) | 1.93609216 |
| 142 | Hepatic necrosis (HP:0002605) | 1.93460158 |
| 143 | Opisthotonus (HP:0002179) | 1.92218910 |
| 144 | Inability to walk (HP:0002540) | 1.91744070 |
| 145 | Chronic diarrhea (HP:0002028) | 1.91529775 |
| 146 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91086336 |
| 147 | Hyperuricemia (HP:0002149) | 1.90810860 |
| 148 | Increased purine levels (HP:0004368) | 1.90810860 |
| 149 | Furrowed tongue (HP:0000221) | 1.88230230 |
| 150 | Polydipsia (HP:0001959) | 1.87958691 |
| 151 | Abnormal drinking behavior (HP:0030082) | 1.87958691 |
| 152 | Ileus (HP:0002595) | 1.87541549 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.86743384 |
| 154 | Elevated alkaline phosphatase (HP:0003155) | 1.85986255 |
| 155 | Hypoalbuminemia (HP:0003073) | 1.84681608 |
| 156 | Abnormal albumin level (HP:0012116) | 1.84681608 |
| 157 | Abnormal urine output (HP:0012590) | 1.81042201 |
| 158 | Hyperaldosteronism (HP:0000859) | 1.79566896 |
| 159 | Abnormality of the pons (HP:0007361) | 1.78206119 |
| 160 | Stomach cancer (HP:0012126) | 1.77785005 |
| 161 | Severe muscular hypotonia (HP:0006829) | 1.76461071 |
| 162 | Fair hair (HP:0002286) | 1.76431595 |
| 163 | Hypoplasia of the pons (HP:0012110) | 1.75932349 |
| 164 | Widely patent fontanelles and sutures (HP:0004492) | 1.75803259 |
| 165 | Mitochondrial inheritance (HP:0001427) | 1.75405495 |
| 166 | 3-Methylglutaconic aciduria (HP:0003535) | 1.74577806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.35355338 |
| 2 | TAOK3 | 5.27672815 |
| 3 | ACVR1B | 4.92291513 |
| 4 | INSRR | 4.17315826 |
| 5 | SIK1 | 3.80601997 |
| 6 | FRK | 3.77438202 |
| 7 | FGFR4 | 3.48190892 |
| 8 | ADRBK2 | 3.38793687 |
| 9 | ERN1 | 3.34906736 |
| 10 | BMPR1B | 3.00921169 |
| 11 | ERBB4 | 2.88293427 |
| 12 | MST1R | 2.79962885 |
| 13 | STK39 | 2.56825657 |
| 14 | ZAK | 2.45348282 |
| 15 | LATS1 | 2.34756581 |
| 16 | CASK | 2.32508389 |
| 17 | TLK1 | 2.14775151 |
| 18 | MAP4K2 | 2.12824962 |
| 19 | TNIK | 1.90269526 |
| 20 | STK38L | 1.83025950 |
| 21 | MAP3K14 | 1.77024712 |
| 22 | PIK3CG | 1.76435548 |
| 23 | MAPK11 | 1.72462539 |
| 24 | MAP2K4 | 1.61335856 |
| 25 | IRAK3 | 1.57529043 |
| 26 | FLT3 | 1.55270444 |
| 27 | PTK6 | 1.46093960 |
| 28 | PIK3CA | 1.45412626 |
| 29 | PRKAA2 | 1.38322295 |
| 30 | TXK | 1.36558838 |
| 31 | MAPK13 | 1.32892565 |
| 32 | TYK2 | 1.31730851 |
| 33 | NEK9 | 1.30359274 |
| 34 | MAP3K4 | 1.24164142 |
| 35 | GRK6 | 1.23827136 |
| 36 | NUAK1 | 1.20007387 |
| 37 | ABL2 | 1.17715637 |
| 38 | DYRK2 | 1.15711858 |
| 39 | PRKG2 | 1.15358342 |
| 40 | PAK3 | 1.15119013 |
| 41 | CAMKK2 | 1.08851585 |
| 42 | ERBB2 | 1.07991288 |
| 43 | AKT3 | 1.07512211 |
| 44 | MAP3K7 | 1.01412408 |
| 45 | EPHA2 | 0.98951186 |
| 46 | JAK2 | 0.98188449 |
| 47 | BRSK2 | 0.97630050 |
| 48 | PRKCE | 0.97272321 |
| 49 | MAPK15 | 0.92713260 |
| 50 | ADRBK1 | 0.90540354 |
| 51 | EPHA3 | 0.89678767 |
| 52 | PRKCG | 0.88652235 |
| 53 | JAK1 | 0.88367899 |
| 54 | TBK1 | 0.87918232 |
| 55 | MST4 | 0.86780862 |
| 56 | PRKAA1 | 0.86359381 |
| 57 | DAPK2 | 0.85860301 |
| 58 | NTRK3 | 0.85785728 |
| 59 | SGK3 | 0.84860424 |
| 60 | MET | 0.83605913 |
| 61 | MAP2K2 | 0.83566633 |
| 62 | MAP2K6 | 0.83137371 |
| 63 | SGK2 | 0.82523187 |
| 64 | TAF1 | 0.81904543 |
| 65 | LMTK2 | 0.77615696 |
| 66 | PKN2 | 0.77188440 |
| 67 | VRK1 | 0.76656341 |
| 68 | PINK1 | 0.75491163 |
| 69 | FGFR2 | 0.74938261 |
| 70 | PRKCZ | 0.72171265 |
| 71 | IKBKE | 0.71752832 |
| 72 | PHKG2 | 0.70072858 |
| 73 | PHKG1 | 0.70072858 |
| 74 | PRKCI | 0.69458751 |
| 75 | RIPK1 | 0.69283120 |
| 76 | MAP3K2 | 0.67645902 |
| 77 | PRKACG | 0.66584130 |
| 78 | CAMK2G | 0.66386977 |
| 79 | EPHB2 | 0.65941926 |
| 80 | IKBKB | 0.65699483 |
| 81 | MUSK | 0.65566497 |
| 82 | MAP3K3 | 0.65382853 |
| 83 | GRK1 | 0.64735300 |
| 84 | NME1 | 0.64674574 |
| 85 | KDR | 0.64151911 |
| 86 | MAP2K7 | 0.63130049 |
| 87 | PTK2 | 0.62667940 |
| 88 | CSK | 0.62569459 |
| 89 | CSNK1G2 | 0.61328619 |
| 90 | CAMK1D | 0.61314235 |
| 91 | MAPK4 | 0.59776520 |
| 92 | DYRK1B | 0.58721739 |
| 93 | MAP3K10 | 0.58372110 |
| 94 | MAP3K6 | 0.57934214 |
| 95 | SGK223 | 0.57262473 |
| 96 | SGK494 | 0.57262473 |
| 97 | NEK2 | 0.56766194 |
| 98 | MAP3K13 | 0.56640204 |
| 99 | CSNK1A1 | 0.56612124 |
| 100 | MARK1 | 0.56005227 |
| 101 | GSK3A | 0.54670700 |
| 102 | PTK2B | 0.53829784 |
| 103 | STK24 | 0.53827218 |
| 104 | MKNK2 | 0.53002962 |
| 105 | VRK2 | 0.52582946 |
| 106 | MAPKAPK3 | 0.52547353 |
| 107 | IRAK1 | 0.51984635 |
| 108 | TIE1 | 0.51929340 |
| 109 | CAMK2A | 0.50479380 |
| 110 | WNK4 | 0.50473266 |
| 111 | WNK3 | 0.49799286 |
| 112 | MAP3K1 | 0.48763092 |
| 113 | MAPKAPK5 | 0.47966040 |
| 114 | PRKCQ | 0.47844610 |
| 115 | CSNK1G3 | 0.47419786 |
| 116 | CDK6 | 0.46543802 |
| 117 | CHUK | 0.46539456 |
| 118 | SIK3 | 0.46161799 |
| 119 | BCR | 0.44332133 |
| 120 | TRIM28 | 0.43275758 |
| 121 | STK11 | 0.42995327 |
| 122 | GRK5 | 0.42119869 |
| 123 | MAP3K11 | 0.40905316 |
| 124 | MAP2K1 | 0.40536125 |
| 125 | IGF1R | 0.40305505 |
| 126 | FGFR3 | 0.39242377 |
| 127 | PRKG1 | 0.39196096 |
| 128 | NTRK2 | 0.39123391 |
| 129 | TGFBR1 | 0.39018681 |
| 130 | IRAK2 | 0.38837534 |
| 131 | CSNK1A1L | 0.38051280 |
| 132 | PRKCA | 0.37858310 |
| 133 | EPHB1 | 0.37777069 |
| 134 | CAMK2D | 0.37360710 |
| 135 | STK3 | 0.36875635 |
| 136 | MAP2K3 | 0.35368804 |
| 137 | ERBB3 | 0.35080358 |
| 138 | PDPK1 | 0.34884042 |
| 139 | TEC | 0.34795211 |
| 140 | NLK | 0.34669851 |
| 141 | TAOK2 | 0.32911881 |
| 142 | PBK | 0.32564607 |
| 143 | MATK | 0.31519151 |
| 144 | ITK | 0.30768288 |
| 145 | MAPK7 | 0.30709872 |
| 146 | MAP3K5 | 0.30331225 |
| 147 | IRAK4 | 0.30054948 |
| 148 | RPS6KA5 | 0.29436399 |
| 149 | CSNK1G1 | 0.29398435 |
| 150 | CAMK4 | 0.26420586 |
| 151 | FER | 0.23765392 |
| 152 | STK16 | 0.22910247 |
| 153 | MYLK | 0.22890002 |
| 154 | EPHA4 | 0.21464221 |
| 155 | OXSR1 | 0.21298796 |
| 156 | PRKACA | 0.19745650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.11331669 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50482606 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.16047789 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86708167 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83123720 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.79692432 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42641039 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41598203 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41063126 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40532743 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39764186 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30389417 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29347896 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23281185 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23192033 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11960869 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.05233475 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99428049 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98874765 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93538235 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93367669 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83420162 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81908539 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81863071 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81787712 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80896420 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79207657 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72336338 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71178860 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71035888 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70583539 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64893841 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.64755133 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60399242 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57868355 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52423987 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50835951 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50297758 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49281448 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44247429 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36320084 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.33909061 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33812236 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31347773 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.31157520 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30458868 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27232148 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15365076 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12993359 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12610246 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11923748 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11874299 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10676326 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09040941 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07686443 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03643724 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02936874 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00778270 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96261422 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95899044 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94831351 |
| 62 | Nicotine addiction_Homo sapiens_hsa05033 | 0.84152326 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.82734199 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82125108 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80730398 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78579752 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74290494 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73512341 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72137401 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69389822 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68571120 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.65721394 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 0.63311148 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60914422 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60585705 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59322316 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.54408685 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51463816 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50596760 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.49536025 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49192219 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47748881 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46056882 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43146817 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43046737 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42878449 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39446778 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38392937 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38033062 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35380831 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.34408498 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34108421 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.34003263 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33950860 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.33844003 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30488620 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28610886 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27511471 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26854312 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26526591 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.24778076 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24112210 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.23112355 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20884706 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20677081 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20661516 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.18060128 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15542119 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05608605 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05418373 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01640765 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00398854 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1725107 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1644396 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1605803 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1505270 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1448851 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1435172 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1245933 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1037894 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1010732 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | -0.0967232 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0919047 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0897768 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0523647 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0293587 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0214079 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0153948 |

